The trademark application LASURSUMAL was filed by Abiogen Pharma S.p.A., a corporation established under the laws of the Italian Republic (the "Applicant"). The application was published for oppositions on May 2, 2021, and it was registered by office on August 9, 2021 without any oppositions.
The application was filed in Italian (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on May 3, 2021.